Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey?
Juliano
Jonathan J
JJ
Taylor
Steve M
SM
Meshnick
Steven R
SR
D000962:Antimalarials / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D016133:Polymerase Chain Reaction / Q000379:methods*; D011739:Pyrimethamine / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013413:Sulfadoxine / Q000627:therapeutic use
D000962:Antimalarials; D013413:Sulfadoxine; D011739:Pyrimethamine